"For what purpose was Masa Son born? It may sound strange, but I think I was born to realize ASI," SoftBank's CEO said.
TOKYO (Reuters) -Japanese technology investor SoftBank Group has launched a joint venture with Tempus AI that aims to analyse personal medical data with artificial intelligence (AI) to come up with treatment recommendations, chief executive officer Masayoshi Son told a briefing in Tokyo. This is the latest in a string of AI investments SoftBank has recently announced as it increases the pace of its investment activity after a muted few years. SoftBank invested around $200 million in Tempus in its series G funding round in April before Tempus listed on the Nasdaq in June.
SoftBank will make this investment as part of a larger $250 million funding round, the report said, citing people familiar with the matter. Perplexity declined to comment, while SoftBank did not respond to a Reuters' request for comment. Perplexity's search tools enable users to get instant answers to questions with sources and citations.